Vincent Ménard

Vincent Ménard is currently the VP of Finance & Business Development at Feldan Therapeutics. Prior to that, they were with Caisse Desjardins des Chutes Montmorency.

Vincent Ménard has a Master of Business Administration (MBA) from Université Laval in the field of finance. Vincent also has a Doctor of Philosophy (Ph.D.) in pharmacy / pharmacie from Université Laval. Additionally, they have a maîtrise (M.Sc.) in pharmacy / pharmacie from Université Laval. Vincent also has a certificate in management / certificat en administration in business administration and management, general from Université Laval. Lastly, they have a bachelor's degree in microbiology, general from Université Laval. Vincent Ménard is also a Chartered Financial Analyst (CFA) Charterholder from the CFA Institute.

Vincent Ménard works with Keith Chiasson - VP, Drug Development, Anna Xue Cheng - Director R&D, Pulmonary Drug Delivery, and Nancy Messier - VP, Drug Discovery. Their manager is François-Thomas Michaud, Board Member & CEO. and Christine Dufour - Business Development Associate reports to Vincent Ménard.